Latest Articles
29. 04. 2022
List of reimbursed medicinal products valid as of 1.5.2022
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
31. 03. 2022
List of reimbursed medicinal products valid as of 1.4.2022
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
10. 03. 2022
SÚKL´s opinion on the inclusion of Ukrainian patients in clinical trials in the Czech Republic
28. 02. 2022
List of reimbursed medicinal products valid as of 1.3.2022
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...